Clinical Trials Browser

Phase 1 × OTHER × Capsules × Clear all

NCT06931119 2025-04-17

Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients

Phase 1 Not yet recruiting

Pruritus

NCT03774680 2019-10-10

Targeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon Cancer

Phase 1 Unknown

Gastrointestinal

Colonic Neoplasms